WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹334 Cr | ₹-315 Cr | ₹-71 Cr | ₹-1,171 Cr | ₹-680 Cr |
What is the latest Cash Flow from Financing Activities ratio of WOCKHARDT ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹334 Cr |
Mar2023 | ₹-315 Cr |
Mar2022 | ₹-71 Cr |
Mar2021 | ₹-1,171 Cr |
Mar2020 | ₹-680 Cr |
How is Cash Flow from Financing Activities of WOCKHARDT Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹334 Cr | Positive | |
Mar2023 | ₹-315 Cr | Negative | |
Mar2022 | ₹-71 Cr | Negative | |
Mar2021 | ₹-1,171 Cr | Negative | |
Mar2020 | ₹-680 Cr | - |
Compare Cash Flow from Financing Activities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹28,409.1 Cr | 2.6% | 14% | 144.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,788.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,283.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹121,853.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,914.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,932.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 2.6% |
14% |
144.1% |
SENSEX | -0.6% |
3.1% |
5.3% |
You may also like the below Video Courses